LINK ALTERNATIF MBL77 - AN OVERVIEW

Not all individuals with CLL require therapy. Despite all latest improvements, the iwCLL still suggests watchful observation for patients with asymptomatic ailment.86 This suggestion is predicated on a minimum of two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,1